Univariate | Multivariate | |||
---|---|---|---|---|
Variable | OR (95% CI) | p-value | aOR (95% CI) | p-value |
Age ≥ 60 years | 0.89 (0.39–2.01) | 0.771 | ||
Male | 1.89 (0.81–4.28) | 0.140 | ||
mFI-5 score > 1 | 0.60 (0.25–1.43) | 0.250 | ||
Tumor pathological type | 1.14 (0.91–1.41) | 0.250 | ||
WHO grade 4 | 0.98 (0.38–2.54) | 0.972 | ||
Tumor volume (cm3) | 1.14 (0.91–1.41) | 0.250 | ||
Preoperative GCS | 0.77 (0.62–0.96) | 0.018 | ||
Preoperative seizure | 0.64 (0.11–3.68) | 0.618 | ||
ASA score > 2 | 3.02 (1.28–7.14) | 0.012 | 3.17 (1.19–8.45) | 0.021 |
ΔWBC > 4.7 (K/µL) | 0.64 (0.28–1.46) | 0.288 | ||
ΔHct > − 4.8 (%) | 2.41 (1.04–5.58) | 0.040 | 3.45 (1.22–9.73) | 0.019 |
ΔHb > − 1.6 (g/dL) | 1.68 (0.74–3.82) | 0.212 | ||
ΔPlatelet > − 33 (K/µL) | 1.13 (0.50–2.57) | 0.771 | ||
ΔCr > − 0.1 (mg/dL) | 1.56 (0.27–8.96) | 0.618 | ||
ΔBUN > − 0.3 (mg/dL) | 2.05 (0.88–4.79) | 0.097 | ||
ΔNa > 1.2 (mmol/L) | 1.26 (0.55–2.85) | 0.585 | ||
ΔK > 0 (mmol/L) | 1.68 (0.48–5.94) | 0.421 | ||
ΔGPT > 0 (U/L) | 1.05 (0.47–2.37) | 0.906 | ||
ΔKeGFR < 0 (mL/min) | 3.03 (1.30–7.06) | 0.010 | 3.99 (1.52–10.53) | 0.005 |
Duration of anesthesia (h) | 1.09 (1.00–1.19) | 0.062 | 1.16 (1.04–1.29) | 0.009 |